|
Market Closed -
Australian S.E.
20:49:24 2026-09-24 EDT
|
5-day change | 1st Jan Change | ||
| 0.0150 AUD | +66.67% |
|
+66.67% | -37.50% |
| 12:56am | Nexalis Therapeutics Appoints Non-Executive Chairman | MT |
| 08-31 | Nexalis Therapeutics Limited Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| Market Cap | 3.8M 2.63M 2.33M 2.18M 1.99M 3.74M 253M 26.4M 10.22M 129M 9.86M 9.65M 414M | P/E 2024 |
-6.17x | P/E 2025 | -3.2x |
|---|---|---|---|---|---|
| Enterprise Value | 4.1M 2.84M 2.52M 2.36M 2.15M 4.04M 273M 28.52M 11.04M 139M 10.66M 10.42M 447M | EV / Sales 2024 |
18.2x | EV / Sales 2025 | 6.13x |
| Free-Float |
29.26% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +66.67% | ||
| 1 week | +66.67% | ||
| 1 month | +66.67% | ||
| 3 months | +15.38% | ||
| 6 months | -11.76% | ||
| Current year | -37.50% |
| 1 month | 0.01 |  | 0.02 |
| Current year | 0.01 | | 0.03 |
| 1 year | 0.01 | | 0.04 |
| 3 years | 0.01 | | 0.05 |
| 5 years | 0.01 | | 0.13 |
| 10 years | 0.01 | | 0.44 |
| Manager | Title | Age | Since |
|---|---|---|---|
Darryl Davies
CEO | Chief Executive Officer | - | 2022-09-26 |
Greg Hammond
DFI | Director of Finance/CFO | - | - |
Rob Jenny
CTO | Chief Tech/Sci/R&D Officer | - | 2022-09-26 |
| Director | Title | Age | Since |
|---|---|---|---|
Darryl Davies
BRD | Director/Board Member | - | 2026-06-24 |
Sean Williams
CHM | Chairman | - | 2021-07-26 |
James Barrie
BRD | Director/Board Member | - | 2026-05-11 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +66.67% | +66.67% | -48.27% | -65.12% | 2.63M | |
| +4.16% | +3.04% | +49.37% | +94.17% | 74.41B | |
| -0.61% | +0.81% | +27.25% | +82.72% | 59.26B | |
| -2.54% | -1.65% | +4.86% | +31.72% | 47.14B | |
| -3.02% | -5.20% | +27.94% | +32.51% | 42.91B | |
| +0.31% | +3.02% | +348.95% | +643.82% | 44.13B | |
| -1.96% | -0.33% | +7.04% | +99.46% | 40.79B | |
| +3.32% | +3.49% | +10.10% | +51.23% | 30.77B | |
| -2.94% | +2.64% | +29.28% | +22.38% | 29.31B | |
| -4.86% | -10.66% | -26.27% | +330.06% | 23.71B | |
| Average | +5.85% | +6.20% | +43.02% | +132.30% | 39.24B | |
| Weighted average by Cap. | -0.36% | -0.32% | +58.48% | +146.08% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 402K 278K 247K 231K 211K 396K 26.78M 2.79M 1.08M 13.64M 1.04M 1.02M 43.81M | 986K 683K 607K 567K 517K 973K 65.74M 6.86M 2.66M 33.48M 2.56M 2.51M 108M |
| Net income | -1.21M -837K -744K -695K -634K -1.19M -80.6M -8.41M -3.26M -41.05M -3.14M -3.08M -132M | -1.62M -1.12M -995K -931K -848K -1.6M -108M -11.26M -4.36M -54.95M -4.21M -4.12M -176M |
| Net Debt | -161K -111K -98.9K -92.49K -84.28K -159K -10.72M -1.12M -433K -5.46M -418K -409K -17.54M | 304K 211K 187K 175K 159K 300K 20.29M 2.12M 820K 10.33M 791K 774K 33.18M |
Employees
-
| Date | Price | Change | Volume |
|---|
- Stock Market
- Stocks
- NX1 Stock
Select your edition
All financial news and data tailored to specific country editions
